HLTH Amsterdam 2026 brought together innovators from across the healthcare ecosystem to showcase technologies moving closer to clinical adoption and real-world deployment.
This report examines 14 emerging healthcare startups working across AI-enabled patient monitoring, contactless health sensing, digital biomarkers, medical imaging, diagnostics, clinical decision support, antimicrobial technologies, and space-based drug discovery.
Going beyond company descriptions, the report assesses how each technology works, the healthcare problem it addresses, its commercialization maturity, funding, clinical or regulatory readiness, and publicly visible IP position.
HLTH Amsterdam 2026 highlighted a healthcare innovation landscape increasingly focused on deployment, integration, and measurable clinical value. AI is moving deeper into EPRs, remote monitoring, and clinical decision-making, while voice, cameras, wearables, and ICU data are enabling more continuous and less intrusive patient monitoring.
At the same time, diagnostics are becoming faster and more accessible through portable and point-of-care technologies. Across the startups analyzed, clinical validation, regulatory readiness, interoperability, and partnerships are emerging as critical factors for adoption and scale.
The broader takeaway is clear: promising healthcare technologies are increasingly being judged not only by what they can do, but by how effectively they fit into existing healthcare systems and move toward real-world use.
Industry Problem | Emerging Solution | Startups to Watch |
Patient deterioration is often detected too late | Continuous monitoring, AI risk prediction, voice biomarkers, and real-time ICU intelligence are being used to identify deterioration earlier. | Noah Labs, Sanome, Deep Breath, Rhythm Diagnostic Systems |
Patient monitoring remains episodic and hardware-dependent | Cameras, wearables, digital biomarkers, and passive signals are enabling continuous and less intrusive health monitoring. | IntelliProve, Shen AI, Ephion Health, Rhythm Diagnostic Systems |
Diagnostics are slow and dependent on centralized laboratories | Portable molecular testing, spectroscopy, AI, and point-of-care platforms are moving diagnostic capabilities closer to patients. | INTU Diagnostics, Nostics, OncoInv, Carna Health |
Healthcare data remains fragmented across systems and devices | EPR integration, interoperable platforms, and unified clinical-data layers are connecting information across the care pathway. | Carna Health, Sanome, Noah Labs, Deep Breath |
Antimicrobial resistance and device-associated infections remain difficult to control | Rapid pathogen identification and antimicrobial functionality built directly into medical-device materials are attacking the problem from diagnosis and prevention. | Nostics, Zonova Technologies |
Traditional drug-discovery models do not always reproduce human biology effectively | Automated microgravity experiments are being explored as an alternative environment for disease modelling and drug screening. | Exobiosphere |
The Bigger Signal
The technologies showcased are addressing healthcare bottlenecks at different points of the value chain—from earlier detection and decentralized diagnostics to workflow integration, infection prevention, and drug discovery.
The common direction is toward healthcare that can generate earlier, more continuous, and more actionable information while reducing dependence on specialized infrastructure and disconnected systems.
Where Healthcare Innovation Is Focusing:
AI, advanced sensing, diagnostics, digital biomarkers, and connected clinical systems are converging to make healthcare more continuous, accessible, and integrated into existing care workflows.
Twente Medical Optics is developing a handheld laser-speckle imaging system that combines perfusion imaging with motion-compensation technology, aiming to provide real-time blood-flow information during procedures and clinical assessments.
Heart-failure deterioration may not be detected until symptoms become severe enough to require hospitalization. At the same time, clinicians often have to review information from multiple disconnected monitoring devices.
Noah Labs combines two complementary platforms:
Machine-learning models analyze subtle changes in patient voice signals and connect them with multimodal telemonitoring data to support earlier clinical review.
Founded
2021
Headquarter
Germany
Funding
~$10.72M
TRL
Ark is commercially deployed; Vox is undergoing clinical validation
IP
Yes
Website
Cancer-screening pathways are generally disease-specific and can depend on specialized infrastructure, making broad population-level screening difficult and costly.
OncoInv supports OncoSeek, a blood-based multi-cancer detection test that combines conventional protein tumor markers with machine learning. The system produces a probability-of-cancer result and may also predict the likely tissue of origin.
A cloud-based model evaluates relationships among multiple protein markers and patient-related clinical factors rather than interpreting each biomarker independently.
Founded
2023
Headquarter
Netherlands
Funding
–
TRL
CE-marked and designed for existing healthcare infrastructure
IP
Yes
Website
Culture-based pathogen identification can take several days. During this waiting period, clinicians may need to prescribe antibiotics empirically, contributing to inappropriate treatment and antimicrobial resistance.
Nostics is developing a portable point-of-care platform designed to identify pathogens directly from biological samples using optical spectral analysis.
The platform combines:
Founded
2020
Headquarter
Netherlands
Funding
~ $6.9M
TRL
Lab-comparable accuracy demonstrated; no regulatory clearance disclosed
IP
Yes
Website
Antimicrobial surface coatings can lose effectiveness after repeated cleaning or chemical exposure. Contaminated medical-device surfaces may therefore continue to contribute to infection and antimicrobial-resistance risks.
Zonova’s Z-ROS technology is intended to be integrated directly into medical-device polymers during manufacturing, allowing antimicrobial functionality to remain part of the device material.
The underlying patent application covers metallic nanoparticle–photosensitizer antimicrobial compositions, including polymer encapsulation and compositions designed to remain active without external light.
Founded
2023
Headquarter
United Kingdom
Funding
~ $2.83M
TRL
Lab-validated material; no disclosed clinical or regulatory milestone
IP
Yes
Website
Periodic nursing observations can miss deterioration occurring between scheduled checks. Single-parameter monitors may also fail to provide enough physiological context for safe discharge and remote follow-up.
Rhythm Diagnostic Systems has developed MultiSense, a wearable patch designed to continuously monitor multiple physiological parameters in hospital and home settings.
The patch combines ECG, photoplethysmography, piezoelectric sensing, temperature sensing, and accelerometry. Data is transmitted to a cloud-connected platform for clinical interpretation and remote surveillance.
Founded
2020
Headquarter
France
Funding
~ $35.73M
TRL
CE-marked Class IIa medical device
IP
Yes
Website
Access the complete 37-page report covering 14 emerging healthcare startups, their technology frameworks, problem-solution fit, commercialization maturity, funding, clinical or regulatory readiness, and selected patent activity.
We provide end-to-end intelligence and scouting services to help you navigate the complex innovation landscape and stay ahead of the competition.
Ready to explore a custom project?
Our analysts are ready to help you build your innovation roadmap.
